NO20080914L - Mellomprodukt for syntetisering av farmasoytisk middel og fremgangsmate for fremstilling av dette - Google Patents

Mellomprodukt for syntetisering av farmasoytisk middel og fremgangsmate for fremstilling av dette

Info

Publication number
NO20080914L
NO20080914L NO20080914A NO20080914A NO20080914L NO 20080914 L NO20080914 L NO 20080914L NO 20080914 A NO20080914 A NO 20080914A NO 20080914 A NO20080914 A NO 20080914A NO 20080914 L NO20080914 L NO 20080914L
Authority
NO
Norway
Prior art keywords
preparation
synthesis
pharmaceutical agent
arylmorpholin
bipyrimidinyl
Prior art date
Application number
NO20080914A
Other languages
English (en)
Norwegian (no)
Inventor
Masahiro Okuyama
Fumiaki Uehara
Hiroshi Iwamura
Kazutoshi Watanabe
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Publication of NO20080914L publication Critical patent/NO20080914L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20080914A 2005-07-22 2008-02-21 Mellomprodukt for syntetisering av farmasoytisk middel og fremgangsmate for fremstilling av dette NO20080914L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005213311 2005-07-22
JP2005267485 2005-09-14
JP2006015436 2006-01-24
PCT/JP2006/314932 WO2007011065A2 (en) 2005-07-22 2006-07-21 Intermediate compound for synthesizing pharmaceutical agent and production method thereof

Publications (1)

Publication Number Publication Date
NO20080914L true NO20080914L (no) 2008-04-18

Family

ID=37311817

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080914A NO20080914L (no) 2005-07-22 2008-02-21 Mellomprodukt for syntetisering av farmasoytisk middel og fremgangsmate for fremstilling av dette

Country Status (14)

Country Link
US (3) US7994315B2 (de)
EP (3) EP1910320A2 (de)
JP (1) JP2009502733A (de)
KR (1) KR20080030675A (de)
CN (2) CN102120741A (de)
AU (1) AU2006270742A1 (de)
CA (1) CA2615515A1 (de)
EA (1) EA200800401A1 (de)
IL (1) IL188786A0 (de)
ME (1) MEP11509A (de)
NO (1) NO20080914L (de)
NZ (1) NZ566009A (de)
TW (1) TW200740779A (de)
WO (1) WO2007011065A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200813015A (en) * 2006-03-15 2008-03-16 Mitsubishi Pharma Corp 2-(cyclic amino)-pyrimidone derivatives
WO2007145203A1 (ja) * 2006-06-13 2007-12-21 Daiichi Fine Chemical Co., Ltd. 光学活性２－アミノ－１－（４－フルオロフェニル）エタノール
AR064660A1 (es) * 2006-12-26 2009-04-15 Mitsubishi Tanabe Pharma Corp Derivados de pirimidinona 6-heterociclica 2-sustituida, medicamentos que los contienen y usos para prevenir y/o tratar enfermedades neurodegenerativas entre otras
TWI432422B (zh) 2007-08-22 2014-04-01 Astrazeneca Ab 環丙基醯胺衍生物
EA201070367A1 (ru) 2007-09-14 2010-08-30 Мицубиси Танабе Фарма Корпорейшн Производное 6-пиримидинилпиримид-4-она
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
TW201043618A (en) 2009-03-10 2010-12-16 Sanofi Aventis Intermediate compound for synthesizing pharmaceutical agent and production method thereof
WO2011019089A1 (en) 2009-08-13 2011-02-17 Mitsubishi Tanabe Pharma Corporation Pyrimidone derivatives used as tau protein kinase 1 inhibitors
WO2011019090A1 (en) 2009-08-13 2011-02-17 Mitsubishi Tanabe Pharma Corporation Pyrimidone derivatives used as tau protein kinase 1 inhibitors
DK2473049T3 (en) 2009-09-04 2019-04-01 Biogen Ma Inc INHIBITORS OF BRUTON'S TYROSINKINASE
SG183274A1 (en) * 2010-02-18 2012-09-27 Astrazeneca Ab Processes for making cyclopropyl amide derivatives and intermediates associated therewith
AR091273A1 (es) 2012-06-08 2015-01-21 Biogen Idec Inc Inhibidores de pirimidinil tirosina quinasa
MX2019000884A (es) 2016-07-21 2019-09-04 Biogen Ma Inc Formas de succinato y composiciones de inhibidores de la tirosina cinasa de bruton.
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) * 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
CN113831218B (zh) * 2020-06-23 2023-11-28 利尔化学股份有限公司 一种制备4-氟苯基环氧乙烷的方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1525298A (fr) 1967-04-05 1968-05-17 Dérivés d'acide orotique et leur préparation
FR2285886A2 (fr) 1974-09-27 1976-04-23 Cerm Cent Europ Rech Mauvernay Procede de synthese de tetrahydro 1,4-oxazines 2,4-disubstituees
GB1559977A (en) 1975-11-25 1980-01-30 Ici Ltd Amines
EG13192A (en) 1976-02-10 1982-12-31 Rhone Poulenc Ind Nouveaux derives du dithiole-1,2 leur preparation et les compositions qui les contiennent
IL57670A (en) 1978-07-03 1982-11-30 Lilly Co Eli Phenethanolamines,their preparation and pharmaceutical formulations comprising them
JPS58103344A (ja) 1981-12-11 1983-06-20 Tanabe Seiyaku Co Ltd アセトフエノン誘導体の製造法
DE3206197A1 (de) 1982-02-20 1983-09-01 Henkel KGaA, 4000 Düsseldorf Uracil-derivate als antiseborrhoische zusaetze fuer kosmetische mittel
FR2555576B1 (fr) 1983-11-25 1986-06-13 Lafon Labor Derives de n-(methoxyphenacyl)-amine, utilisation notamment en therapeutique et procede de preparation
JPS60152450A (ja) 1984-01-23 1985-08-10 Nippon Soda Co Ltd α−アミノケトンの製造方法
JPH0798782B2 (ja) 1987-02-06 1995-10-25 三井石油化学工業株式会社 アミノケトン類の製造方法
JPH03200751A (ja) 1989-12-27 1991-09-02 Fukui Kagaku Kogyo Kk ２―アミノ―１―（４―ヒドロキシフェニル）―エタノン鉱酸塩の製造法
GB9124512D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel compounds
WO1995002407A1 (fr) 1993-07-14 1995-01-26 Yamanouchi Pharmaceutical Co., Ltd. Neuroprotecteur et nouvel ester orotique
CA2220759C (en) 1995-05-12 2009-01-20 Nisshin Flour Milling Co. Ltd. 1,4-benzodioxin derivatives
US6515023B2 (en) * 2000-01-31 2003-02-04 Merck & Co., Inc. Thrombin receptor antagonists
GB0030171D0 (en) 2000-12-11 2001-01-24 Cipla Ltd Process for preparing isomers of salbutamol
EP1389185A2 (de) * 2001-05-24 2004-02-18 Fujisawa Pharmaceutical Co., Ltd. Aminoalkoholderivate
KR100754596B1 (ko) * 2001-09-21 2007-09-05 미쯔비시 웰 파마 가부시키가이샤 3-치환-4-피리미돈 유도체
ITMI20022389A1 (it) * 2002-11-12 2004-05-13 Nicox Sa Farmaci per le disfunzioni sessuali.
RS51442B (en) 2002-12-10 2011-04-30 Pfizer Inc. MORPHOLINE DERIVATIVES USED AS DOPAMINE AGONISTS IN TREATMENT I.A. SEXUAL DYSFUNCTIONS
TWI357408B (en) * 2003-03-26 2012-02-01 Mitsubishi Tanabe Pharma Corp 3-substituted-4-pyrimidone derivatives
JP2007514782A (ja) * 2003-12-17 2007-06-07 リブ−エックス ファーマシューティカルズ，インコーポレイテッド ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法
JP2005213311A (ja) 2004-01-28 2005-08-11 Yaskawa Electric Corp 熱硬化性樹脂組成物の製造方法
WO2005082869A1 (en) * 2004-02-20 2005-09-09 Pharmacia & Upjohn Company Llc Method for the preparation of aryl ethers
JP2005267485A (ja) 2004-03-22 2005-09-29 Canon Inc 画像形成システム
JP2006015436A (ja) 2004-06-30 2006-01-19 Honda Motor Co Ltd 監視ロボット
TW200621760A (en) * 2004-09-09 2006-07-01 Mitsubishi Pharma Corp 2-morpholino-4-pyrimidone compound
EP1805164B9 (de) * 2004-09-29 2011-09-07 Mitsubishi Tanabe Pharma Corporation 6-(pyridinyl)-4-pyrimidonderivate als inhibitoren der tau-proteinkinase-1

Also Published As

Publication number Publication date
EP2221305A1 (de) 2010-08-25
CN102050820A (zh) 2011-05-11
IL188786A0 (en) 2008-08-07
WO2007011065A2 (en) 2007-01-25
CN102120741A (zh) 2011-07-13
JP2009502733A (ja) 2009-01-29
US7994315B2 (en) 2011-08-09
EP1910320A2 (de) 2008-04-16
EP2221304A1 (de) 2010-08-25
US20110251385A1 (en) 2011-10-13
TW200740779A (en) 2007-11-01
KR20080030675A (ko) 2008-04-04
CA2615515A1 (en) 2007-01-25
US20110257392A1 (en) 2011-10-20
MEP11509A (en) 2011-12-20
US20090156804A1 (en) 2009-06-18
NZ566009A (en) 2010-12-24
EA200800401A1 (ru) 2008-06-30
AU2006270742A1 (en) 2007-01-25
WO2007011065A3 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
NO20080914L (no) Mellomprodukt for syntetisering av farmasoytisk middel og fremgangsmate for fremstilling av dette
NO20075365L (no) 3,4-substituerte pyrrolidinderivater for behandling av hypertensjon
NO20083315L (no) 3,5-substituert piperidin-bestanddeler som renin-inhibitorer
NO20064456L (no) Thiadiazolidinoner som GSK-3 inhibitorer
NO20075973L (no) Dipeptidyl-peptidase-IV-inhibitorer
Singh et al. Synthesis of natural flutimide and analogous fully substituted pyrazine-2, 6-diones, endonuclease inhibitors of influenza virus
WO2007006534A3 (en) Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity
TN2009000327A1 (fr) Procede pour la preparation d'un derive de benzimidazole
WO2006125621A8 (en) Substituted piperidines as renin inhibitors
NO20082748L (no) Aryl-isoksazol-4-yl-imidazo[1, 5-a]pyridinderivater
NO20076195L (no) Nye 2-azetidinonderivater for behandling av hyperlipidemiske sykdommer
NO20073926L (no) Pyrazolforbindelser som modulerer aktivitet av CDK-, GSK- og aurorakinaser
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
NO20090166L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
NO20091683L (no) Kjemiske forbindelser
NO20076682L (no) Nye pyridinanaloger
NO20073170L (no) Kaspaseinhibitorer og anvendelse derav
Gerpe et al. 5-Nitrofuranes and 5-nitrothiophenes with anti-Trypanosoma cruzi activity and ability to accumulate squalene
WO2006074924A8 (en) 3,4,(5)-substituted tetrahvdropyridines
WO2006055434A3 (en) Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease
WO2007060662A3 (en) Process for preparing pyridinamines and novel polymorphs thereof
NO20065501L (no) Lxr reseptor modulstorer.
WO2006128659A3 (en) Piperazine derivative renin inhibitors.
NO20076000L (no) Aminosyrederivater
EA201070367A1 (ru) Производное 6-пиримидинилпиримид-4-она

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application